In experimental models of acute and chronic renal disease, activation of ASK1 and subsequent activation of downstream APKs induce inflammation, fibrosis, and apoptosis and are associated with human kidney disease [26]. This evidence concerns the gene MAP3K5 and chronic kidney disease.